{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:05:30Z","timestamp":1792101930478,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clbc.2020.07.014","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T19:57:40Z","timestamp":1595707060000},"page":"e74-e79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0210-4394","authenticated-orcid":false,"given":"Sushma","family":"Gaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Babb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2311-7442","authenticated-orcid":false,"given":"Yiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.07.014_bib2","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1016\/j.clbc.2018.06.013","article-title":"Male breast cancer: an updated Surveillance, Epidemiology, and End Results data analysis","volume":"18","author":"Liu","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2020.07.014_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1148\/radiol.2019190971","article-title":"Breast cancer screening in high-risk men: a 12-year longitudinal observational study of male breast imaging utilization and outcomes","volume":"293","author":"Gao","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2020.07.014_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10549-019-05338-1","article-title":"Mammographic screening in male patients at high risk for breast cancer: is it worth it?","volume":"177","author":"Marino","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2020.07.014_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2016161174","article-title":"National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2020.07.014_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiol.2411051504","article-title":"Performance benchmarks for screening mammography","volume":"241","author":"Rosenberg","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2020.07.014_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2214\/AJR.15.14312","article-title":"The national mammography database: preliminary data","volume":"206","author":"Lee","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2020.07.014_bib8","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/djn329","article-title":"Prospective evaluation of risk factors for male breast cancer","volume":"100","author":"Brinton","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2020.07.014_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.07.014_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2020.07.014_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jmg.2009.075176","article-title":"Risk of breast cancer in male BRCA2 carriers","volume":"47","author":"Evans","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2020.07.014_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2020.07.014_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1524-4741.2011.01185.x","article-title":"Screening mammography in men with BRCA mutation: is there a role?","volume":"18","author":"Freedman","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2020.07.014_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/radiol.2302030360","article-title":"Screening-detected breast cancer in a man with BRCA2 mutation: case report","volume":"230","author":"Brenner","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2020.07.014_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer cases and breast cancer families","volume":"13","author":"Couch","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.clbc.2020.07.014_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1593\/neo.04193","article-title":"BRCA2 mutations in 154 Finnish male breast cancer patients","volume":"6","author":"Syrjakoski","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.clbc.2020.07.014_bib17","first-page":"1367","article-title":"BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease","volume":"58","author":"Haraldsson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2020.07.014_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(95)91383-1","article-title":"Linkage to BRCA2 region in hereditary male breast cancer","volume":"346","author":"Thorlacius","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2020.07.014_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2020.07.014_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12885-016-2414-y","article-title":"Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis","volume":"16","author":"Gargiulo","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2020.07.014_bib21","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","article-title":"Multidisciplinary meeting on male breast cancer: summary and research recommendations","volume":"28","author":"Korde","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.07.014_bib23","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.19.00792","article-title":"Management of male breast cancer: ASCO guideline summary","author":"Hassett","year":"2020","journal-title":"JCO Oncol Pract"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920301804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920301804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:36Z","timestamp":1761513576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920301804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1526820920301804"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.07.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}